Default company panoramic image


Ecoeos answers the question of who is at risk from environmental toxins and how people can protect themselves and their families.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location San Francisco, CA, USA
  • Currency USD
  • Founded July 2010
  • Employees 3
  • Website

Company Summary

Ecoeos develops clinically-validated DNA tests to measure personal susceptibiilty to environmental toxins. Ecoeos' first product is a mail-in genetic test that reveals a person's mercury susceptibility. Mercury, a vile neurotoxin, can harm developing fetuses and children. Future products focus on toxins such as lead and pesticides. Surveys (N=1,100) indicate early adopters are 15M women of reproductive age who are environmentally sensitive.


  • Default avatar
    Dr. Gregory Stock

    Founder Signum Biosciences, Founder, Program on Medicine & Technology at UCLA's Medical School. PhD Biophysics, Johns Hopkins; MBA, Harvard, best selling author

  • Default avatar
    Lisa Conte

    CEO, Napo Pharmaceuticals, CEO, Shaman Pharmaceuticals.
    BS, Pharmacology, UCSD, MBA, Dartmouth

  • Default avatar
    David Ewing Duncan
    Strategic Advisor/Founder

    Award-winning journalist (NYTs, NPR, Fortune) and bestselling author. Founding Director of the Center for Life Science Policy, UC Berkeley

  • Default avatar
    Margaret Coles
    Chief Marketing Officer/Advisor

    Led product launches at GSK, Wyeth, Chevrolet, Zoomerang, Healthline and Wageworks. Degree in Marketing Metrics, Wharton

  • Default avatar
    Christine Janae
    VP Customer Experience and Design/Advisor

    Experienced in consumer and web product development. Completed major projects for Mayo Clinic, Philips, HP, Razorfish, Hasbro, and Schick.
    BFA, University of Washington


  • Default avatar
    Matthew Rossiter, Fenwick and West

Previous Investors

  • Default avatar
    Various angel investors